• 1. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. An insight into the origin of room-temperature ferromagnetism in SnO2 and Mn-doped SnO2 quantum dots: an experimental and DFT approach?
  Dhamodaran Manikandan,S. Amirthapandian,I. S. Zhidkov,A. I. Kukharenko,S. O. Cholakh,Ramaswamy Murugan Phys. Chem. Chem. Phys., 2018,20, 6500-6514
• 4. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzodioxoles Benzodioxoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzodioxoles

5-Bromo-6-fluoro-1,3-benzodioxole (CAS No. 94670-75-4): A Comprehensive Overview

5-Bromo-6-fluoro-1,3-benzodioxole (CAS No. 94670-75-4) is a halogenated benzodioxole derivative that has garnered significant attention in the field of organic chemistry and pharmaceutical research. This compound, characterized by its unique molecular structure, serves as a versatile intermediate in the synthesis of various bioactive molecules. The presence of both bromine and fluorine atoms in its structure enhances its reactivity, making it a valuable building block in medicinal chemistry and material science.

The molecular formula of 5-bromo-6-fluoro-1,3-benzodioxole is C₇H₄BrFO₂, with a molecular weight of approximately 219.01 g/mol. Its benzodioxole core, a fused bicyclic system consisting of a benzene ring and a 1,3-dioxole ring, provides a stable framework for further chemical modifications. The bromo and fluoro substituents at the 5 and 6 positions, respectively, contribute to its electronic and steric properties, influencing its reactivity in cross-coupling reactions and other synthetic transformations.

One of the most notable applications of 5-bromo-6-fluoro-1,3-benzodioxole is its role as a key intermediate in the synthesis of pharmaceutical compounds. Researchers have utilized this compound to develop potential drug candidates targeting various diseases, including central nervous system (CNS) disorders and inflammatory conditions. The fluorine atom, in particular, is known to improve the metabolic stability and bioavailability of drug molecules, making 5-bromo-6-fluoro-1,3-benzodioxole a valuable scaffold in drug design.

In addition to its pharmaceutical applications, 5-bromo-6-fluoro-1,3-benzodioxole has found use in material science. Its unique electronic properties make it a promising candidate for the development of organic semiconductors and luminescent materials. The incorporation of halogenated benzodioxoles into polymeric systems has been explored to enhance the performance of optoelectronic devices, such as organic light-emitting diodes (OLEDs) and photovoltaic cells.

The synthesis of 5-bromo-6-fluoro-1,3-benzodioxole typically involves the halogenation of a pre-existing benzodioxole framework. Modern synthetic routes often employ transition metal-catalyzed reactions to achieve high selectivity and yield. For instance, palladium-catalyzed cross-coupling reactions have been successfully applied to introduce the bromo and fluoro substituents at specific positions on the benzodioxole ring. These methods not only improve the efficiency of the synthesis but also reduce the environmental impact by minimizing the use of hazardous reagents.

Recent advancements in synthetic chemistry have further expanded the utility of 5-bromo-6-fluoro-1,3-benzodioxole. Researchers are now exploring its potential in click chemistry and bioorthogonal reactions, where its halogenated structure can serve as a handle for further functionalization. These developments align with the growing demand for sustainable and efficient synthetic methodologies in both academia and industry.

The market for 5-bromo-6-fluoro-1,3-benzodioxole is expected to grow steadily, driven by its increasing applications in pharmaceuticals and advanced materials. Companies specializing in fine chemicals and custom synthesis are actively investing in the production of this compound to meet the rising demand from research institutions and pharmaceutical manufacturers. Additionally, the compound's compatibility with green chemistry principles has made it a preferred choice for environmentally conscious applications.

From a regulatory perspective, 5-bromo-6-fluoro-1,3-benzodioxole is generally regarded as safe for research and industrial use when handled according to standard safety protocols. Its non-toxic nature and low environmental persistence make it a sustainable option for various applications. However, users are advised to consult material safety data sheets (MSDS) and adhere to local regulations to ensure safe handling and disposal.

In conclusion, 5-bromo-6-fluoro-1,3-benzodioxole (CAS No. 94670-75-4) is a multifaceted compound with significant potential in pharmaceuticals, material science, and synthetic chemistry. Its unique structural features, combined with its reactivity and versatility, make it a valuable asset for researchers and industries alike. As scientific advancements continue to uncover new applications for this compound, its importance in modern chemistry is expected to grow even further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)